Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Un-Happy Valley Nutrition: infant formula company collapses as director and CFO walk out

  • In News
  • July 5, 2023
  • Alinda Gupta
Un-Happy Valley Nutrition: infant formula company collapses as director and CFO walk out

There is little joy in the Happy Valley (ASX: HVM) offices today, as the infant formula company enters voluntary administration. “It is disappointing to announce the appointment of administrators today,” the Chairman of the Company, Kevin Bush, stated grimly in an announcement.

Due to dwindling global infant milk supply, HVM was able to thrive during the extremely challenging COVID period, even as New Zealand was in lockdown for nearly three years. However, with demand for dairy products suspended in limbo, Happy Valley has few recourses, the most optimal of which is entering voluntary administration.

The board of the Company has appointed McGrathNicol to be the Company’s administrators. They will “exercise all or any of the powers conferred upon them as administrators by the Companies Act 1993 (Administrators), effective immediately to HVM and its subsidiary Five Redland Road Limited”, as per its report.

With the new guns walking in, the Company has witnessed a slew of resignations. Grant Horan has resigned as a director effective immediately, following a brief stint. Horan took the helm in May this year, replacing Randolph van der Burgh who resigned on May 22, 2023. The Company’s CFO Richard Chew also resigned on June 26.

Bush added, “Our ability to identify and pursue a dairy protein strategy in the last eight months saw a significant amount of interest and we were able to secure offtake agreements as previously announced. As a result of this, HVM had several investors undertake due diligence and negotiations since April until Friday last week; however, unfortunately, the current market conditions of increasing high interest rates, tightening milk supply and the continued emergence of China domestic milk supply has left HVM unable to secure the necessary funding to continue at this point.”

Happy Valley’s boom, like that of many others, had come as China’s dwindling milk supply compelled the country to import infant milk formula. Companies like Bubs (ASX: BUB) were exporting their infant milk formula worldwide, including the US. However, with countries now prioritising self-sufficiency and milk prices set to soften, the outlook for Happy Valley and other infant milk formula companies remains uncertain.

With just about $228k in the bank as of the March quarter and nada in unused financing facilities, Happy Valley has been recording a trajectory of losses. In H1 FY23, these losses shot up by 16% to about $2.8 million. Compared to December 2021’s $3.7 million, Happy Valley ended December 2022 with only $889k in cash equivalents. Now, its fate rests in the hands of the voluntary administrators.

As per the New Zealand Companies Act 1993, a first statutory meeting of creditors must be held within eight business days after the administration begins and is expected to take place on 18 July 2023.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx bub
  • asx hvm
  • Grant Horan
  • Happy Valley
  • HVM
  • Kevin Bush
  • mcgrathnicol
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.